http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16071262

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 924
issn 0028-4793
1533-4406
issueIdentifier 10
pageRange 914-924
publicationName The New England journal of medicine
startingPage 914
bibliographicCitation Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM; Pasireotide B2305 Study Group. A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med. 2012 Mar 08;366(10):914–24. doi: 10.1056/nejmoa1105743. PMID: 22397653.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dff34fde3e3b2d1735cad4d1f103ee2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2751ac8c71f77e7053a6a087e57d564c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab6de73f5a62f904ac15c6184b3acfe3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f468870a7229b7c18d4e91709737814
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cfe5c4bf31451bf045816970dba75cb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24b9242af8a2974791e52ad8fa6315e7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b18dd77764610e4d93c02948b4f83229
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a9d4e5a11f33aff374c4b6e75013fe1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51ca26593af1a248095b46e7294b13fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed3ab827f4d9358f5e279bc46a800a39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14039cdf4fa56b51397db6349e302d64
date 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1056/nejmoa1105743
https://pubmed.ncbi.nlm.nih.gov/22397653
isPartOf https://portal.issn.org/resource/ISSN/0028-4793
https://portal.issn.org/resource/ISSN/1533-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
discusses http://id.nlm.nih.gov/mesh/M0507457
http://id.nlm.nih.gov/mesh/M0010707
http://id.nlm.nih.gov/mesh/M0000499
http://id.nlm.nih.gov/mesh/M0020152
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013004Q000031
http://id.nlm.nih.gov/mesh/D047748Q000188
http://id.nlm.nih.gov/mesh/D006854Q000652
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006854Q000032
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D013004Q000009
http://id.nlm.nih.gov/mesh/D012008
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D013004Q000627
http://id.nlm.nih.gov/mesh/D012463Q000737
http://id.nlm.nih.gov/mesh/D006854Q000097
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000324Q000097
http://id.nlm.nih.gov/mesh/D047748Q000652
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D047748Q000097
http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16161315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44377662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9941444
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102601394
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44291156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_51251df01484cc547f4d59bd93cd7512

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128344927

Total number of triples: 72.